Results for "trastuzumab emtansina" | Prospecte.ro

Medication leaflets

KADCYLA 100mg concentrated powder infusion solution EGIS ORIGINAL MEDICINE

Chemical substance: trastuzumab emtansine

ATC code: L01FD01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Her2 (human epidermal growth factor receptor 2) inhibitors

Prescription

P-RF
KADCYLA 100mg powder for concentrate for solution for infusion EGIS ORIGINAL MEDICINE

Chemical substance: trastuzumab emtansine

ATC code: L01FD01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Her2 (human epidermal growth factor receptor 2) inhibitors

Price

7133.18 RON

List

C2

Prescription

P-RF
KADCYLA 160mg concentrated powder infusion solution EGIS ORIGINAL MEDICINE

Chemical substance: trastuzumab emtansine

ATC code: L01FD01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Her2 (human epidermal growth factor receptor 2) inhibitors

Prescription

P-RF
KADCYLA 160mg powder for concentrate for solution for infusion EGIS ORIGINAL MEDICINE

Chemical substance: trastuzumab emtansine

ATC code: L01FD01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Her2 (human epidermal growth factor receptor 2) inhibitors

Price

11369.99 RON

List

C2

Prescription

P-RF

Results for the substance trastuzumab emtansina

trastuzumab emtansine

Indicated for: breast cancer

L01FD01 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Her2 (human epidermal growth factor receptor 2) inhibitors